Skip to main content
Press release August 6, 2026

Celcuity Schedules Release of Second Quarter 2026 Financial Results and Webcast/Conference Call

Celcuity Inc. (CELC)

MINNEAPOLIS, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a commercial-stage biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tumor indications, today announced that it will release its financial results for
View original release